Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (NH): Expansion of cannabis growing facilities shut down by gov. veto

Not far from downtown Peterborough, N.H., is a discreet building, somewhat removed from the main road. No signs are posted, leaving no way for outsiders to learn what the building contains.

It's for good reason — state law dictates that no markers are allowed to indicate what's inside. To get in, visitors must pass through the main entrance, the gowning room and a second set of doors to the main warehouse. Inside is GraniteLeaf Cannabis, one of New Hampshire's three marijuana production companies. The plants are behind another set of locks. Finished products are stored in a bank vault.

Efforts to legalize recreational cannabis fell short at the State House again this year, but the therapeutic program qualifies people who've been diagnosed with eligible medical conditions to legally receive cannabis as part of their medical care. Demand for therapeutic cannabis is building: The most recent available data shows there were over 13,000 certified patients in 2022, and people in the industry estimate that number has grown closer to 15,000 now. A new law will also add anxiety to the list of eligible conditions, paving the way for even more certified patients to join the ranks.

However, Gov. Chris Sununu vetoed a bill last month that would've allowed ATCs to operate additional cultivation locations, including greenhouses. "The legislation provides scant detail regarding safety, security and location requirements," Sununu said in his reasoning for the veto. "These details are necessary to ensure appropriate controls on a regulated substance."

Read more at vnews.com

Publication date: